MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

ELISA in Relapsed/Refractory MM

Phase 2

Not yet recruiting

Conditions: Relapsed Refractory Multiple Myeloma (RRMM)
Relapsed Refractory Multiple Myeloma

Interventions: Drug: elranatamab
Drug: Isatuximab SC
Device: Isatuximab SC-OBDS

First Posted Date: 2025-02-18

Last Posted Date: 2025-02-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT06832865

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Open Pilot Trial of a Mind-Body Intervention for Patients With Chronic Hip Pain

Not Applicable

Recruiting

Conditions: Hip Pain Chronic
Hip Pain
Mind-Body Therapies

First Posted Date: 2025-02-11

Last Posted Date: 2025-04-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT06820242

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Recruiting

Conditions: Immune Thrombocytopenia

First Posted Date: 2025-02-10

Last Posted Date: 2025-02-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT06817395

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effects Multimodal Mind and Body Approach for MCI

Not Applicable

Recruiting

Conditions: Mild Cognitive Impairment

First Posted Date: 2025-02-07

Last Posted Date: 2025-02-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT06814483

Locations: 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States

Outpatient Epcoritamab As 2L in NTE R/R DLBCL

Phase 2

Not yet recruiting

Conditions: Relapsed Large B-cell Lymphoma
Refractory Large B-cell Lymphoma

Interventions: Drug: Epcoritamab

First Posted Date: 2025-02-06

Last Posted Date: 2025-02-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT06811272

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Assessing Tenapanor as a Treatment of CF-related Constipation.

Phase 3

Not yet recruiting

Conditions: Cystic Fibrosis
Constipation

Interventions: Drug: Tenapanor

First Posted Date: 2025-02-05

Last Posted Date: 2025-05-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT06810167

Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship

Not Applicable

Recruiting

Conditions: Insomnia Chronic

First Posted Date: 2025-02-04

Last Posted Date: 2025-04-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 198

Registration Number: NCT06807086

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

Not Applicable

Not yet recruiting

Conditions: Metastatic Breast Cancer

First Posted Date: 2025-01-28

Last Posted Date: 2025-05-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 400

Registration Number: NCT06795529

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

School-Based Living in Families with Emotions Training

Not Applicable

Completed

Conditions: Living in Families with Emotions

First Posted Date: 2025-01-27

Last Posted Date: 2025-01-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT06793878

Locations: 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States

Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Not Applicable

Not yet recruiting

Conditions: Advanced Lung Cancer
Dyspnea

First Posted Date: 2025-01-24

Last Posted Date: 2025-01-28

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 420

Registration Number: NCT06791057

Locations: 🇺🇸
University of Miami, Coral Gables, Florida, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Home Terms & Conditions Privacy Policy